Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12659)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 7, 2016 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Imamura T, Komatsu S, Ichikawa D, Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Arita T, Konishi H, Shiozaki A, Morimura R, Ikoma H, Okamoto K, Otsuji E. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. World J Gastroenterol 2016; 22(25): 5627-5641 [PMID: 27433079 DOI: 10.3748/wjg.v22.i25.5627] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i25/5627.htm |
| Number | Citing Articles |
| 1 |
Bin Zhou, Jian‐Wei Xu, Yu‐Gang Cheng, Jing‐Yue Gao, San‐Yuan Hu, Lei Wang, Han‐Xiang Zhan. Early detection of pancreatic cancer: Where are we now and where are we going?. International Journal of Cancer 2017; 141(2): 231 doi: 10.1002/ijc.30670
|
| 2 |
Ana García-Casas, Dolores C García-Olmo, Damián García-Olmo. Further the liquid biopsy: Gathering pieces of the puzzle of genometastasis theory. World Journal of Clinical Oncology 2017; 8(5): 378-388 doi: 10.5306/wjco.v8.i5.378
|
| 3 |
Aline Barhli, Jérôme Cros, Laurent Bartholin, Cindy Neuzillet. Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future. Digestive and Liver Disease 2018; 50(10): 979 doi: 10.1016/j.dld.2018.08.009
|
| 4 |
Karolina Elżbieta Kaczor-Urbanowicz, Jordan Cheng, Jonathan C. King, Alireza Sedarat, Stephen J. Pandol, James J. Farrell, David T.W. Wong, Yong Kim. Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers. Pancreas 2020; 49(9): 1141 doi: 10.1097/MPA.0000000000001662
|
| 5 |
Esther Llop, Pedro E Guerrero, Adrià Duran, Sílvia Barrabés, Anna Massaguer, María José Ferri, Maite Albiol-Quer, Rafael de Llorens, Rosa Peracaula. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma. World Journal of Gastroenterology 2018; 24(24): 2537-2554 doi: 10.3748/wjg.v24.i24.2537
|
| 6 |
Taisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Wataru Okajima, Takuma Ohashi, Jun Kiuchi, Keiji Nishibeppu, Hirotaka Konishi, Atsushi Shiozaki, Ryo Morimura, Hisashi Ikoma, Toshiya Ochiai, Kazuma Okamoto, Hiroki Taniguchi, Eigo Otsuji. Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06137-8
|
| 7 |
Linjing Liu, Xingjian Chen, Olutomilayo Olayemi Petinrin, Weitong Zhang, Saifur Rahaman, Zhi-Ri Tang, Ka-Chun Wong. Machine Learning Protocols in Early Cancer Detection Based on Liquid Biopsy: A Survey. Life 2021; 11(7): 638 doi: 10.3390/life11070638
|
| 8 |
Sona Ciernikova, Julie Earl, María Laura García Bermejo, Viola Stevurkova, Alfredo Carrato, Bozena Smolkova. Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?. International Journal of Molecular Sciences 2020; 21(11): 4091 doi: 10.3390/ijms21114091
|
| 9 |
Uma Prabhakar, Yalia Jayalakshmi, C. Katherine Wang. Nanotheranostics for Cancer Applications. Bioanalysis 2019; 5: 33 doi: 10.1007/978-3-030-01775-0_3
|
| 10 |
Zhengbo Song, Wenxian Wang, Min Li, Junjun Liu, Yiping Zhang. Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients. Lung Cancer 2019; 136: 23 doi: 10.1016/j.lungcan.2019.08.004
|
| 11 |
Zeeshan Sattar, Saeed Ali, Ishtiaq Hussain, Farhan Sattar, Sana Hussain, Sarfraz Ahmad. Theranostic Approach for Pancreatic Cancer. 2019; : 51 doi: 10.1016/B978-0-12-819457-7.00002-5
|
| 12 |
Anelis Maria Marin, Heloisa Bruna Soligo Sanchuki, Guilherme Naccache Namur, Miyuki Uno, Dalila Luciola Zanette, Mateus Nóbrega Aoki. Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer. Biomedicines 2023; 11(4): 1069 doi: 10.3390/biomedicines11041069
|
| 13 |
Lei Zhang, Martin H. Bluth, Amarpreet Bhalla. Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gallbladder, and Extrahepatic Biliary Tract. Clinics in Laboratory Medicine 2018; 38(2): 367 doi: 10.1016/j.cll.2018.03.003
|
| 14 |
Akihiko Kawahara, Hideyuki Abe, Kazuya Murata, Hidenobu Ishii, Koichi Azuma, Yorihiko Takase, Satoshi Hattori, Yoshiki Naito, Jun Akiba. Screening system for epidermal growth factor receptor mutation detection in cytology cell‐free DNA of cerebrospinal fluid based on assured sample quality. Cytopathology 2019; 30(2): 144 doi: 10.1111/cyt.12660
|
| 15 |
Michihiro Kudou, Toshiyuki Kosuga, Eigo Otsuji. Artificial intelligence in gastrointestinal cancer: Recent advances and future perspectives. Artificial Intelligence in Gastroenterology 2020; 1(4): 71-85 doi: 10.35712/aig.v1.i4.71
|
| 16 |
Irma G. Domínguez-Vigil, Ana K. Moreno-Martínez, Julia Y. Wang, Michael H. A. Roehrl, Hugo A. Barrera-Saldaña. The dawn of the liquid biopsy in the fight against cancer. Oncotarget 2018; 9(2): 2912 doi: 10.18632/oncotarget.23131
|
| 17 |
Xiao‐Xia Chen, Wei Chen, Yi‐Long Liu, Can‐Xiang Lin, Mengmeng Li, Wen‐Jie Chen, Shang‐Hang Xie, Dong‐Feng Lin, Su‐Mei Cao. Development and validation of a flexible DNA extraction (PAN) method for liquid biopsy of multiple sample types. Journal of Clinical Laboratory Analysis 2021; 35(9) doi: 10.1002/jcla.23962
|
| 18 |
Eleonora Rofi, Caterina Vivaldi, Marzia Del Re, Elena Arrigoni, Stefania Crucitta, Niccola Funel, Stefano Fogli, Enrico Vasile, Gianna Musettini, Lorenzo Fornaro, Alfredo Falcone, Romano Danesi. The Emerging Role of Liquid Biopsy in Diagnosis, Prognosis and Treatment Monitoring of Pancreatic Cancer. Pharmacogenomics 2019; 20(1): 49 doi: 10.2217/pgs-2018-0149
|
| 19 |
Etienne Buscail, Alexandre Chauvet, Pascaline Quincy, Olivier Degrandi, Camille Buscail, Isabelle Lamrissi, Isabelle Moranvillier, Charline Caumont, Severine Verdon, Alain Brisson, Marion Marty, Laurence Chiche, Christophe Laurent, Veronique Vendrely, François Moreau-Gaudry, Aurelie Bedel, Sandrine Dabernat. CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma. Translational Oncology 2019; 12(11): 1395 doi: 10.1016/j.tranon.2019.07.009
|
| 20 |
Sarah Owen, Emily Prantzalos, Valerie Gunchick, Vaibhav Sahai, Sunitha Nagrath. Synergistic Analysis of Circulating Tumor Cells Reveals Prognostic Signatures in Pilot Study of Treatment-Naïve Metastatic Pancreatic Cancer Patients. Biomedicines 2022; 10(1): 146 doi: 10.3390/biomedicines10010146
|
| 21 |
Hamza Al Balushi, Purnashree Chowdhury, Hisham M Babu, Abdur Rehman, Syed Faqeer Hussain Bokhari, Lina M Al-Tarawneh, Abedallah J Al-Adwan, Meher Cheran, Srikar P Chilla, Anirudh R Addula, Maaz Amir. The Potential of Salivary Biomarkers in Early Detection of Pancreatic Ductal Adenocarcinoma: A Systematic Review. Cureus 2024; doi: 10.7759/cureus.55003
|
| 22 |
Marzia Del Re, Caterina Vivaldi, Eleonora Rofi, Enrico Vasile, Mario Miccoli, Chiara Caparello, Paolo Davide d’Arienzo, Lorenzo Fornaro, Alfredo Falcone, Romano Danesi. Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-08297-z
|
| 23 |
Emanuele Neri, Marzia Del Re, Fabiola Paiar, Paola Erba, Paola Cocuzza, Daniele Regge, Romano Danesi. Radiomics and liquid biopsy in oncology: the holons of systems medicine. Insights into Imaging 2018; 9(6): 915 doi: 10.1007/s13244-018-0657-7
|
| 24 |
Ishtiaq Hussain, Mamoon Ur Rashid, Jamaluddin Saeed, Zarghoona Wajid, Deepika Sarvepalli, Effa Zahid, Sundas Jehanzeb, Sarfraz Ahmad. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 239 doi: 10.1007/978-981-15-5471-1_14
|
| 25 |
Taher Halawa, Saleh Baeesa, Motaz M Fadul, Adnan A Badahdah, Maryam Enani, Amany A Fathaddin , Dania Kawass, Alaa Alkhotani, Basem Bahakeem, Maher Kurdi. The Role of Liquid Biopsy in the Diagnosis and Prognosis of WHO Grade 4 Astrocytoma. Cureus 2023; doi: 10.7759/cureus.41221
|
| 26 |
Diego Fernández-Lázaro, Juan Luis García Hernández, Alberto Caballero García, Alfredo Córdova Martínez, Juan Mielgo-Ayuso, Juan Jesús Cruz-Hernández. Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer’s Biomarkers. Diagnostics 2020; 10(4): 215 doi: 10.3390/diagnostics10040215
|
| 27 |
Maryam Koopaie, Sajad Kolahdooz, Mahnaz Fatahzadeh, Zainab Abdulkareem Aleedawi. Salivary noncoding RNA in the diagnosis of pancreatic cancer: Systematic review and meta‐analysis. European Journal of Clinical Investigation 2022; 52(12) doi: 10.1111/eci.13848
|
| 28 |
Minako Nagai, Masayuki Sho, Takahiro Akahori, Kenji Nakagawa, Kota Nakamura. Application of liquid biopsy for surgical management of pancreatic cancer. Annals of Gastroenterological Surgery 2020; 4(3): 216 doi: 10.1002/ags3.12317
|
| 29 |
Hu Li. Screening and identification of serum exosomal protein ZNF587B in liquid biopsy for ovarian cancer diagnosis. American Journal of Cancer Research 2024; 14(4): 1904 doi: 10.62347/RBTM1834
|
| 30 |
David Anz, Ignazio Piseddu, Marlies Köpke, Ujjwal M. Mahajan, Julia Mayerle. Clinical Pancreatology for Practising Gastroenterologists and Surgeons. 2021; : 425 doi: 10.1002/9781119570097.ch53
|
| 31 |
Taisuke Imamura, Shuhei Komatsu, Keiji Nishibeppu, Jun Kiuchi, Takuma Ohashi, Hirotaka Konishi, Atsushi Shiozaki, Yusuke Yamamoto, Ryo Moriumura, Hisashi Ikoma, Toshiya Ochiai, Eigo Otsuji. Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12676-x
|
| 32 |
Louis Buscail, Barbara Bournet, Pierre Cordelier. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nature Reviews Gastroenterology & Hepatology 2020; 17(3): 153 doi: 10.1038/s41575-019-0245-4
|
| 33 |
Yan Du, Kai Yao, Qingbo Feng, Feiyu Mao, Zechang Xin, Peng Xu, Jie Yao, Pierfrancesco Franco. Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/6656337
|
| 34 |
Bor-Uei Shyr, Bor-Shiuan Shyr, Shih-Chin Chen, Shih-Ching Chang, Yi-Ming Shyr, Shin-E Wang. Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer. Cancers 2021; 13(10): 2313 doi: 10.3390/cancers13102313
|
| 35 |
Hemant Joshi. Oncology: Genomics, Precision Medicine and Therapeutic Targets. 2023; : 77 doi: 10.1007/978-981-99-1529-3_4
|
| 36 |
Diego Fernández-Lázaro, Juan Luis García Hernández, Alberto Caballero García, Aurora Caballero del Castillo, María Villaverde Hueso, Juan Jesús Cruz-Hernández. Clinical Perspective and Translational Oncology of Liquid Biopsy. Diagnostics 2020; 10(7): 443 doi: 10.3390/diagnostics10070443
|
| 37 |
Yasunori Uesato, Naoki Sasahira, Masato Ozaka, Takashi Sasaki, Mitsuhisa Takatsuki, Hitoshi Zembutsu, Jung Weon Lee. Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis. PLOS ONE 2020; 15(7): e0235623 doi: 10.1371/journal.pone.0235623
|
| 38 |
Etienne Buscail, Charlotte Maulat, Fabrice Muscari, Laurence Chiche, Pierre Cordelier, Sandrine Dabernat, Catherine Alix-Panabières, Louis Buscail. Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma. Cancers 2019; 11(6): 852 doi: 10.3390/cancers11060852
|
| 39 |
Giorgia Beffagna, Alessandro Sammarco, Chiara Bedin, Chiara Romualdi, Marta Mainenti, Antonio Mollo, Laura Cavicchioli, Silvia Ferro, Davide Trez, Raffaella De Maria, Donato Nitti, Andrea Saccani, Michelangelo Campanella, Marco Agostini, Valentina Zappulli, Kristy L. Richards. Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index. PLOS ONE 2017; 12(1): e0169454 doi: 10.1371/journal.pone.0169454
|
| 40 |
Shasha Guan, Guochao Deng, Jingjie Sun, Quanli Han, Yao Lv, Tianhui Xue, Lijuan Ding, Tongxin Yang, Niansong Qian, Guanghai Dai. Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.926260
|
| 41 |
Amy Makler, Waseem Asghar. Exosomal biomarkers for cancer diagnosis and patient monitoring. Expert Review of Molecular Diagnostics 2020; 20(4): 387 doi: 10.1080/14737159.2020.1731308
|
| 42 |
Marsha Mariya Kappan, Joby George. <i>In Silico</i> Pharmacokinetic and Molecular Docking Studies of Natural Plants against Essential Protein KRAS for Treatment of Pancreatic Cancer. Journal of Natural Remedies 2023; : 1107 doi: 10.18311/jnr/2023/31947
|
| 43 |
Bor-Shiuan Shyr, Shih-Chin Chen, Yi-Ming Shyr, Shin-E Wang, Bor-Uei Shyr. Cell-free DNA as a prognostic and predictive biomarker in resectable distal common bile duct cancer. Journal of the Chinese Medical Association 2023; 86(9): 835 doi: 10.1097/JCMA.0000000000000923
|
| 44 |
A. Kawahara, C. Fukumitsu, K. Azuma, T. Taira, H. Abe, Y. Takase, K. Murata, E. Sadashima, S. Hattori, Y. Naito, J. Akiba. A Combined test using both cell sediment and supernatant cell‐free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung cancer patients. Cytopathology 2018; 29(2): 150 doi: 10.1111/cyt.12517
|
| 45 |
Margaret Thomas, Paola Marcato. Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum. Cancers 2018; 10(4): 101 doi: 10.3390/cancers10040101
|
| 46 |
Victoria Heredia-Soto, Nuria Rodríguez-Salas, Jaime Feliu. Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?. Cancers 2021; 13(8): 1986 doi: 10.3390/cancers13081986
|
| 47 |
Peter McAnena, James Brown, Michael Kerin. Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer. Cancers 2017; 9(1): 5 doi: 10.3390/cancers9010005
|
| 48 |
Mohamadmahdi Samandari, María Gil Julia, Alistair Rice, Antonios Chronopoulos, Armando E. del Rio Hernandez. Liquid biopsies for management of pancreatic cancer. Translational Research 2018; 201: 98 doi: 10.1016/j.trsl.2018.07.008
|
| 49 |
J.-Matthias Löhr, Maximilian Kordes, Wiktor Rutkowski, Rainer Heuchel, Maria Gustafsson-Liljefors, Aman Russom, Mats Nilsson. Overcoming diagnostic issues in precision treatment of pancreatic cancer. Expert Review of Precision Medicine and Drug Development 2018; 3(3): 189 doi: 10.1080/23808993.2018.1476061
|
| 50 |
Samuel Corless, Saskia Höcker, Sylvia Erhardt. Centromeric RNA and Its Function at and Beyond Centromeric Chromatin. Journal of Molecular Biology 2020; 432(15): 4257 doi: 10.1016/j.jmb.2020.03.027
|
| 51 |
Lumir Kunovsky, Pavla Tesarikova, Zdenek Kala, Radek Kroupa, Petr Kysela, Jiri Dolina, Jan Trna. The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/5389820
|